Market Estimates
Valuation Metrics
Financials
Trading Trends
HALO News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Halozyme Therapeutics Inc (HALO) stock price today?
The current price of HALO is 72.47 USD — it has increased 0.47 % in the last trading day.
What is Halozyme Therapeutics Inc (HALO)'s business?
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. It also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED. It also has a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon.
What is the price predicton of HALO Stock?
Wall Street analysts forecast HALO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HALO is 77.63 USD with a low forecast of 56.00 USD and a high forecast of 92.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Halozyme Therapeutics Inc (HALO)'s revenue for the last quarter?
Halozyme Therapeutics Inc revenue for the last quarter amounts to 354.26M USD, increased 22.12 % YoY.
What is Halozyme Therapeutics Inc (HALO)'s earnings per share (EPS) for the last quarter?
Halozyme Therapeutics Inc. EPS for the last quarter amounts to 1.43 USD, increased 36.19 % YoY.
What changes have occurred in the market's expectations for Halozyme Therapeutics Inc (HALO)'s fundamentals?
How many employees does Halozyme Therapeutics Inc (HALO). have?
Halozyme Therapeutics Inc (HALO) has 350 emplpoyees as of January 10 2026.
What is Halozyme Therapeutics Inc (HALO) market cap?
Today HALO has the market capitalization of 8.52B USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260108215035_86c66e9984ebd289a6a4ecb0752c3762.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F14e4ab57bcc7df4527a23638b8cbb70bbb2099c662b52b5922555aca0917981b.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260108210427_b82c2b668dbd4fba05a6d03bdf81ec75.jpeg&w=384&q=75)